Christopher Peetz, CEO: Mirum Pharmaceuticals MIRM Sell · Filed 06/02

Trade details

Type: Insider sale
Amount: $246,253.28
Shares · price: 2,602 sh · $94.64 a share
Held after: 221,707 sh
Stock: Mirum Pharmaceuticals MIRM
Person: Christopher PeetzCEO
Trade date: 26/06/01
Filed: 26/06/02
Days to filing: 1 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Mirum Pharmaceuticals trades, last 26 weeks

What else happened in Mirum Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/02~07/01

Christopher Peetz's recent trades

Christopher PeetzCEO
Planned sale10b5-1 planMirum Pharmaceuticals
Planned sale10b5-1 plan
Mirum Pharmaceuticals
MIRM
$3M
30,000 sh
$3M
Filed 09/01
Traded 09/01
Christopher PeetzCEO
Planned sale10b5-1 planMirum Pharmaceuticals
Planned sale10b5-1 plan
Mirum Pharmaceuticals
MIRM
$2M
20,000 sh
$2M
Filed 08/10
Traded 08/10
Christopher PeetzCEO
Planned sale10b5-1 planMirum Pharmaceuticals
Planned sale10b5-1 plan
Mirum Pharmaceuticals
MIRM
$2.4M
20,000 sh
$2.4M
Filed 07/06
Traded 07/06
Christopher PeetzCEO
Sell10b5-1 planMirum Pharmaceuticals
Sell10b5-1 plan
Mirum Pharmaceuticals
MIRM
$1.6M
16,595 sh
$1.6M
Filed 06/02
Traded 06/01
Christopher PeetzCEO
Sell10b5-1 planMirum Pharmaceuticals
Sell10b5-1 plan
Mirum Pharmaceuticals
MIRM
$665.9K
6,926 sh
$665.9K
Filed 06/02
Traded 06/01

Christopher Peetz, CEO — sold $246.3K of Mirum Pharmaceuticals MIRM · 1.2% of holdings · 10b5-1 plan | Whalegun